Beluga whale pVHL enhances HIF-2 alpha activity via inducing HIF-2 alpha proteasomal degradation under hypoxia

Aquatic mammals, such as cetaceans experience various depths, with accordingly diverse oxygenation, thus, cetaceans have developed adaptations for hypoxia, but mechanisms underlying this tolerance to low oxygen are unclear. Here we analyzed VHL and HIF-2 alpha, in the hypoxia signaling pathway. Vari...

Full description

Bibliographic Details
Published in:Oncotarget
Main Authors: Bi, Jianling, Hu, Bo, Wang, Jing, Liu, Xing, Zheng, Jinsong, Wang, Ding, Xiao, Wuhan
Format: Report
Language:English
Published: IMPACT JOURNALS LLC 2017
Subjects:
VHL
Online Access:http://ir.ihb.ac.cn/handle/342005/31444
http://ir.ihb.ac.cn/handle/342005/31445
https://doi.org/10.18632/oncotarget.15038
id ftchinacadsciihb:oai:ir.ihb.ac.cn:342005/31445
record_format openpolar
spelling ftchinacadsciihb:oai:ir.ihb.ac.cn:342005/31445 2023-05-15T15:41:40+02:00 Beluga whale pVHL enhances HIF-2 alpha activity via inducing HIF-2 alpha proteasomal degradation under hypoxia Bi, Jianling Hu, Bo Wang, Jing Liu, Xing Zheng, Jinsong Wang, Ding Xiao, Wuhan 2017-06-27 http://ir.ihb.ac.cn/handle/342005/31444 http://ir.ihb.ac.cn/handle/342005/31445 https://doi.org/10.18632/oncotarget.15038 英语 eng IMPACT JOURNALS LLC ONCOTARGET http://ir.ihb.ac.cn/handle/342005/31444 http://ir.ihb.ac.cn/handle/342005/31445 doi:10.18632/oncotarget.15038 beluga whale cetaceans hypoxia HIF-2 alpha VHL Oncology Cell Biology TUMOR-SUPPRESSOR PROTEIN HIGH-ALTITUDE ADAPTATION BAIJI LIPOTES-VEXILLIFER DELPHINAPTERUS-LEUCAS HIF-ALPHA MOLE-RAT FINLESS PORPOISE DIVING BEHAVIOR YANGTZE-RIVER WHITE WHALES 期刊论文 2017 ftchinacadsciihb https://doi.org/10.18632/oncotarget.15038 2019-08-23T00:03:47Z Aquatic mammals, such as cetaceans experience various depths, with accordingly diverse oxygenation, thus, cetaceans have developed adaptations for hypoxia, but mechanisms underlying this tolerance to low oxygen are unclear. Here we analyzed VHL and HIF-2 alpha, in the hypoxia signaling pathway. Variations in VHL are greater than HIF-2 alpha between cetaceans and terrestrial mammals, and beluga whale VHL (BW-VHL) promotes HIF-2 alpha degradation under hypoxia. BW-VHL catalyzes BW-HIF-2 alpha to form K48-linked polyubiquitin chains mainly at the lysine 429 of BW-HIF-2 alpha (K429) and induces BW-HIF-2 alpha for proteasomal degradation. W100 within BW-VHL is a key site for BW-VHL functionally and BW-VHL enhances transcriptional activity of BW-HIF-2 alpha under hypoxia. Our data therefore reveal that BW-VHL has a unique function that may contribute to hypoxic adaptation. Report Beluga Beluga whale Beluga* Delphinapterus leucas Institute of Hydrobiology, Chinese Academy of Sciences: IHB OpenIR Oncotarget 8 26 42272 42287
institution Open Polar
collection Institute of Hydrobiology, Chinese Academy of Sciences: IHB OpenIR
op_collection_id ftchinacadsciihb
language English
topic beluga whale
cetaceans
hypoxia
HIF-2 alpha
VHL
Oncology
Cell Biology
TUMOR-SUPPRESSOR PROTEIN
HIGH-ALTITUDE ADAPTATION
BAIJI LIPOTES-VEXILLIFER
DELPHINAPTERUS-LEUCAS
HIF-ALPHA
MOLE-RAT
FINLESS PORPOISE
DIVING BEHAVIOR
YANGTZE-RIVER
WHITE WHALES
spellingShingle beluga whale
cetaceans
hypoxia
HIF-2 alpha
VHL
Oncology
Cell Biology
TUMOR-SUPPRESSOR PROTEIN
HIGH-ALTITUDE ADAPTATION
BAIJI LIPOTES-VEXILLIFER
DELPHINAPTERUS-LEUCAS
HIF-ALPHA
MOLE-RAT
FINLESS PORPOISE
DIVING BEHAVIOR
YANGTZE-RIVER
WHITE WHALES
Bi, Jianling
Hu, Bo
Wang, Jing
Liu, Xing
Zheng, Jinsong
Wang, Ding
Xiao, Wuhan
Beluga whale pVHL enhances HIF-2 alpha activity via inducing HIF-2 alpha proteasomal degradation under hypoxia
topic_facet beluga whale
cetaceans
hypoxia
HIF-2 alpha
VHL
Oncology
Cell Biology
TUMOR-SUPPRESSOR PROTEIN
HIGH-ALTITUDE ADAPTATION
BAIJI LIPOTES-VEXILLIFER
DELPHINAPTERUS-LEUCAS
HIF-ALPHA
MOLE-RAT
FINLESS PORPOISE
DIVING BEHAVIOR
YANGTZE-RIVER
WHITE WHALES
description Aquatic mammals, such as cetaceans experience various depths, with accordingly diverse oxygenation, thus, cetaceans have developed adaptations for hypoxia, but mechanisms underlying this tolerance to low oxygen are unclear. Here we analyzed VHL and HIF-2 alpha, in the hypoxia signaling pathway. Variations in VHL are greater than HIF-2 alpha between cetaceans and terrestrial mammals, and beluga whale VHL (BW-VHL) promotes HIF-2 alpha degradation under hypoxia. BW-VHL catalyzes BW-HIF-2 alpha to form K48-linked polyubiquitin chains mainly at the lysine 429 of BW-HIF-2 alpha (K429) and induces BW-HIF-2 alpha for proteasomal degradation. W100 within BW-VHL is a key site for BW-VHL functionally and BW-VHL enhances transcriptional activity of BW-HIF-2 alpha under hypoxia. Our data therefore reveal that BW-VHL has a unique function that may contribute to hypoxic adaptation.
format Report
author Bi, Jianling
Hu, Bo
Wang, Jing
Liu, Xing
Zheng, Jinsong
Wang, Ding
Xiao, Wuhan
author_facet Bi, Jianling
Hu, Bo
Wang, Jing
Liu, Xing
Zheng, Jinsong
Wang, Ding
Xiao, Wuhan
author_sort Bi, Jianling
title Beluga whale pVHL enhances HIF-2 alpha activity via inducing HIF-2 alpha proteasomal degradation under hypoxia
title_short Beluga whale pVHL enhances HIF-2 alpha activity via inducing HIF-2 alpha proteasomal degradation under hypoxia
title_full Beluga whale pVHL enhances HIF-2 alpha activity via inducing HIF-2 alpha proteasomal degradation under hypoxia
title_fullStr Beluga whale pVHL enhances HIF-2 alpha activity via inducing HIF-2 alpha proteasomal degradation under hypoxia
title_full_unstemmed Beluga whale pVHL enhances HIF-2 alpha activity via inducing HIF-2 alpha proteasomal degradation under hypoxia
title_sort beluga whale pvhl enhances hif-2 alpha activity via inducing hif-2 alpha proteasomal degradation under hypoxia
publisher IMPACT JOURNALS LLC
publishDate 2017
url http://ir.ihb.ac.cn/handle/342005/31444
http://ir.ihb.ac.cn/handle/342005/31445
https://doi.org/10.18632/oncotarget.15038
genre Beluga
Beluga whale
Beluga*
Delphinapterus leucas
genre_facet Beluga
Beluga whale
Beluga*
Delphinapterus leucas
op_relation ONCOTARGET
http://ir.ihb.ac.cn/handle/342005/31444
http://ir.ihb.ac.cn/handle/342005/31445
doi:10.18632/oncotarget.15038
op_doi https://doi.org/10.18632/oncotarget.15038
container_title Oncotarget
container_volume 8
container_issue 26
container_start_page 42272
op_container_end_page 42287
_version_ 1766374557376053248